Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 99 of 1,261
  1. US 12065416

    cGAS antagonist compounds

    The Board of Regents of the University of Texas System Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  2. US 12064433

    Pyridone A2R antagonists

    Arcus Biosciences, Inc. Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  3. US 12064511

    Lipid nanoparticles containing silyl lipids for use in vaccines and gene therapy

    The Regents of the University of California Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  4. US 12064476

    Zika virus immunogenic compositions

    Regents of the University of Minnesota Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  5. US 12065404

    C4-carboxylic acid-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  6. US 12065485

    Treatment of staphylococcal disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  7. US 12064507

    Composition and method for oral treatment of leukemia

    Provectus Pharmatech, Inc. Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  8. US 12064472

    Southern cattle tick vaccine product

    The United States of America, as represented by the Secretary of Agriculture Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  9. US 12064411

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  10. US 12064402

    Binge behavior regulators

    CLEARMIND MEDICINE INC. Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  11. US 12064473

    Cancer vaccines targeting Survivin and uses thereof

    Inovio Pharmaceuticals, Inc. Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  12. US 12065489

    Claudin-6 antibodies and drug conjugates

    The Regents of the University of California Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  13. US 12064398

    Parenteral formulations

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  14. US 12066246

    Target residual moisture content for lyophilized drug product

    REGENERON PHARMACEUTICALS, INC. Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  15. US 12064512

    Silyl lipids suitable for enhanced delivery of anti-viral therapeutics

    The Regents of the University of California Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  16. US 12064488

    Nitroxide containing amyloid binding agents for imaging and therapeutic uses

    The Regents of the University of California Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  17. US 12064399

    Use of cannabinoids in the treatment of epilepsy

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  18. US 12065432

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  19. US 12064413

    Methods of treating melanoma with S-equol

    The Board of Regents of the University of Texas System Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  20. US 12065490

    Chimeric antigen receptors and methods of making

    The Board of Regents of the University of Texas System Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  21. US 12064502

    Peptide exhibiting wrinkle-improving activity and uses thereof

    CAREGEN CO., LTD. Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  22. US 12064514

    Ultrasound-sensitive peptide particles for spatially resolved molecule delivery

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFERβ€”NATIONAL INSTITUTES OF HEALTH Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  23. US 12064516

    Pharmaceutical formulations and uses thereof

    Aldeyra Therapeutics, Inc. Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  24. US 12065498

    Methods of making bispecific anti-CD307E and anti-BCMA chimeric antigen receptors and uses of the same

    Cell Design Labs, Inc. Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.